Edward A. Lew, MD
Adjunct Assistant Professor
Boston University Chobanian & Avedisian School of Medicine

MD, New York University School of Medicine
MPH, Yale University School of Medicine
BS, Columbia University

Dr. Lew, MD is a practicing Gastroenterologist in Jamaica Plain, MA. Dr. Lew graduated from New York University School of Medicine in 1992 and has been in practice for 26 years. He completed a residency at UCLA Medical Center. Dr. Lew also specializes in Internal Medicine.

VA Boston Healthcare System

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Fang M, Lew E, Klein M, Sebo T, Su Y, Goyal R. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues. Am J Gastroenterol. 2004 Oct; 99(10):1887-94. PMID: 15447746
  2. Lew EA. Clarithromycin, lansoprazole, and metronidazole eradicated Helicobacter pylori infection in chronic renal insufficiency. ACP J Club. 2004 Mar-Apr; 140(2):40. PMID: 15122860
  3. Lew EA, Stoffel EM. Natalizumab for active Crohn's disease. N Engl J Med. 2003 Apr 17; 348(16):1599; author reply 1599. PMID: 12700383; DOI: 10.1056/NEJM200304173481615;
  4. Metz DC, Forsmark C, Lew EA, Starr JA, Soffer EF, Bochenek W, Pisegna JR. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Am J Gastroenterol. 2001 Dec; 96(12):3274-80. PMID: 11774936; DOI: 10.1111/j.1572-0241.2001.05325.x;
  5. Lew EA, Goyal RK. The enigma of short-segment Barrett's esophagus. Indian J Gastroenterol. 2001 Jul-Aug; 20(4):130-1. PMID: 11497168
  6. Lew EA, Pisegna JR, Starr JA, Soffer EF, Forsmark C, Modlin IM, Walsh JH, Beg M, Bochenek W, Metz DC. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Gastroenterology. 2000 Apr; 118(4):696-704. PMID: 10734021; DOI: 10.1016/s0016-5085(00)70139-9;
  7. Lew EA. Review article: pharmacokinetic concerns in the selection of anti-ulcer therapy. Aliment Pharmacol Ther. 1999 Oct; 13 Suppl 5:11-6. PMID: 10555604
  8. Lew EA, Lewin KJ, Zarchy T, Pisegna JR. Adenocarcinoma of the colon with neuroendocrine features and secretory diarrhea. Am J Gastroenterol. 1999 Jun; 94(6):1692-4. PMID: 10364049; DOI: 10.1111/j.1572-0241.1999.01167.x;
  9. Lew EA, Barbuti RC, Kovacs TO, Sytnic B, Humphries TJ, Walsh JH. An ascending single-dose safety and tolerance study of an oral formulation of rabeprazole (E3810). Aliment Pharmacol Ther. 1998 Jul; 12(7):667-72. PMID: 9701531
  10. Lew EA, Poles MA, Dieterich DT. Diarrheal diseases associated with HIV infection. Gastroenterol Clin North Am. 1997 Jun; 26(2):259-90. PMID: 9187925
Showing 10 of 18 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 18 publications over 11 distinct years, with a maximum of 3 publications in 1997


Contact for Mentoring:
Lew's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department